Oncology Institute Inc (NASDAQ: TOI) is 494.20% higher on its value in year-to-date trading and has touched a low of $0.13 and a high of $3.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TOI stock was last observed hovering at around $2.42 in the last trading session, with the day’s gains setting it 0.45%.
Currently trading at $2.87, the stock is 18.82% and 7.30% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.63 million and changing 18.60% at the moment leaves the stock 141.53% off its SMA200. TOI registered 828.80% gain for a year compared to 6-month gain of 809.96%. The firm has a 50-day simple moving average (SMA 50) of $2.6748 and a 200-day simple moving average (SMA200) of $1.188295.
The stock witnessed a 10.38% loss in the last 1 month and extending the period to 3 months gives it a 112.59%, and is 17.62% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.19% over the week and 9.48% over the month.
Oncology Institute Inc (TOI) has around 825 employees, a market worth around $263.79M and $403.15M in sales. Profit margin for the company is -13.10%. Distance from 52-week low is 2190.50% and -18.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.51%).
The EPS is expected to grow by 46.48% this year
51.0 institutions hold shares in Oncology Institute Inc (TOI), with institutional investors hold 38.15% of the company’s shares. The shares outstanding are 88.93M, and float is at 45.65M with Short Float at 5.27%. Institutions hold 34.63% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.75 million shares valued at $2.19 million. The investor’s holdings represent 6.4005 of the TOI Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 3.36 million shares valued at $1.55 million to account for 4.5263 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.78 million shares representing 2.4025 and valued at over $0.82 million, while KENT LAKE CAPITAL LLC holds 2.3574 of the shares totaling 1.75 million with a market value of $0.81 million.
Oncology Institute Inc (TOI) Insider Activity
The most recent transaction is an insider sale by M33 Growth I L.P., the company’s Director. SEC filings show that M33 Growth I L.P. sold 673,676 shares of the company’s common stock on Jun 05 ’25 at a price of $3.05 per share for a total of $2.05 million. Following the sale, the insider now owns 13.95 million shares.
Oncology Institute Inc disclosed in a document filed with the SEC on Jun 05 ’25 that M33 Growth I L.P. (Director) sold a total of 76,324 shares of the company’s common stock. The trade occurred on Jun 05 ’25 and was made at $3.05 per share for $0.23 million. Following the transaction, the insider now directly holds 1.27 million shares of the TOI stock.
Still, SEC filings show that on Jun 03 ’25, Hively Brad (Director) disposed off 1,976,137 shares at an average price of $2.87 for $5.67 million. The insider now directly holds 603,501 shares of Oncology Institute Inc (TOI).
